--- Sources Neeland et al., Changes in lean body mass with GLP-1-based therapies and mitigation strategies , Diabetes, Obesity and Metabolism (2024): Jensterle et al., Rethinking Muscle Health Assessment in GLP-1-Based Therapies for Obesity: Beyond Lean Mass , DOM (2026): Wilding et al., STEP 1 body composition exploratory analysis: LEAN-PREP randomised controlled trial protocol (2025): Function and Lean Mass Preservation With Resistance Exercise During GLP-1RA Treatment, ClinicalTrials.gov: WHO Guidelines on Physical Activity and Sedentary Behaviour: Wegovy Singapore availability and prescription status:
Surgical options like gastric bypass or sleeve gastrectomy enhance metabolic function, promote sustained weight loss, and resolve conditions like Type 2 diabetes without the ongoing challenge of medication management
IM injections are the standard for rapidly restoring B12 levels, particularly in severe cases and patients with absorption issues
Stay at 12:12 for at least the first 4 to 8 weeks of GLP-1 therapy, or until side effects stabilize and your dose is established
Chen PH et al